| User's Publication |
|
20629
Stransky LA, Vigeant SM, Huang B, West D, Denize T, Walton E, Signoretti S, Kaelin WG Jr.
Sensitivity of VHL mutant kidney cancers to HIF2 inhibitors does not require an intact p53 pathway.
Proc Natl Acad Sci U S A
2022
119(14):e2120403119
PubMed ID: 35357972
DOI: 10.1073/pnas.2120403119
|
|
16366
Emberley E, Pan A, Chen J, Dang R, Gross M, Huang T, Li W, MacKinnon A, Singh D, Sotirovska N, Steggerda SM, Wang T, Parlati F.
The glutaminase inhibitor telaglenastat enhances the antitumor activity of signal transduction inhibitors everolimus and cabozantinib in models of renal cell carcinoma
PLoS One
2021
16(11):e0259241
PubMed ID: 34731180
DOI: 10.1371/journal.pone.0259241
|
|
3749
Zou Y, Palte MJ, Deik AA, Li H, Eaton JK, Wang W, Tseng YY, Deasy R, Kost-Alimova M, Dančík V, Leshchiner ES, Viswanathan VS, Signoretti S, Choueiri TK, Boehm JS, Wagner BK, Doench JG, Clish CB, Clemons PA, Schreiber SL.
A GPX4-dependent cancer cell state underlies the clear-cell morphology and confers sensitivity to ferroptosis.
Nat Commun
2019
10(1):1617
PubMed ID: 30962421
DOI: 10.1038/s41467-019-09277-9
|
|
10839
Tsuchida A, Senda M, Ito A, Saito S, Kiso M, Ando T, Harduin-Lepers A, Matsuda A, Furukawa K, Furukawa K.
Roles of GalNAc-disialyl Lactotetraosyl Antigens in Renal Cancer Cells.
Sci Rep
2018
8:7017
PubMed ID: 29728594
DOI: 10.1038/s41598-018-25521-6
|
|
3740
Sinha R, Winer AG, Chevinsky M, Jakubowski C, Chen YB, Dong Y, Tickoo SK, Reuter VE, Russo P, Coleman JA, Sander C, Hsieh JJ, Hakimi AA.
Analysis of renal cancer cell lines from two major resources enables genomics-guided cell line selection.
Nat Commun. 2
2017
8:15165
PubMed ID: 28489074
DOI: 10.1038/ncomms15165
|
|
8356
Hosono T, Tanaka T, Tanji K, Nakatani T, Kamitani T.
NUB1, an interferon-inducible protein, mediates anti-proliferative actions and apoptosis in renal cell carcinoma cells through cell-cycle regulation.
Br. J. Cancer
2010
102:873-82
PubMed ID: 20160729
DOI: 10.1038/sj.bjc.6605574
|
|
6387
Minami K, Chano T, Kawakami T, Ushida H, Kushima R, Okabe H, Okada Y, Okamoto K.
DNMT3L is a novel marker and is essential for the growth of human embryonal carcinoma.
Clin Cancer Res
2010
16(10):2751-9
PubMed ID: 20460473
DOI: 10.1158/1078-0432.CCR-09-3338
|
|
6393
Inowa T, Hishikawa K, Matsuzaki Y, Isagawa T, Takeuchi T, Aburatani H, Kitamura T, Fujita T.
GADD45β Determines Chemoresistance and Invasive Growth of Side Population Cells of Human Embryonic Carcinoma.
Stem Cells Int
2010
2010:782967
PubMed ID: 21048853
DOI: 10.4061/2010/782967
|
|
3719
van Haaften G et al
Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer.
Nat Genet
2009
41(5):521-3
PubMed ID: 19330029
DOI: 10.1038/ng.349
|
|
8851
Domoto T, Miyama Y, Suzuki H, Teratani T, Arai K, Sugiyama T, Takayama T, Mugiya S, Ozono S, Nozawa R.
Evaluation of S100A10, annexin II and B-FABP expression as markers for renal cell carcinoma.
Cancer Sci.
2007
98:77-82
PubMed ID: 17083565
DOI: 10.1111/j.1349-7006.2006.00355.x
|
|
18947
Senda M, Ito A, Tsuchida A, Hagiwara T, Kaneda T, Nakamura Y, Kasama K, Kiso M, Yoshikawa K, Katagiri Y, Ono Y, Ogiso M, Urano T, Furukawa K, Oshima S, Furukawa K.
Identification and expression of a sialyltransferase responsible for the synthesis of disialylgalactosylgloboside in normal and malignant kidney cells: downregulation of ST6GalNAc VI in renal cancers
Biochem J
2007
402(3):459-70
PubMed ID: 17123352
DOI: 10.1042/BJ20061118
|
|
3396
Yamada, Daisuke, Kikuchi, Shinji, Williams, Yuko N, Sakurai-Yageta, Mika, Masuda, Mari, Maruyama, Tomoko, Tomita, Kyoichi, Gutmann, David H, Kakizoe, Tadao, Kitamura, Tadaichi, Kanai, Yae, Murakami, Yoshinori
Promoter hypermethylation of the potential tumor suppressor DAL-1/4.1B gene in renal clear cell carcinoma.
Int J Cancer
2006
118:916-23
PubMed ID: 16152585
DOI: 10.1002/ijc.21450
|
|
5012
Kawakami T, Chano T, Minami K, Okabe H, Okada Y, Okamoto K.
Imprinted DLK1 is a putative tumor suppressor gene and inactivated by epimutation at the region upstream of GTL2 in human renal cell carcinoma.
Hum Mol Genet
2006
15(6):821-30
PubMed ID: 16439445
DOI: 10.1093/hmg/ddl001
|
|
2661
Kasuya, Yutaka, Hosaka, Yoshio, Matsushima, Hisashi, Goto, Toshitaka, Kitamura, Tadaichi, Okuyama, Akira
Prominent induction of cyclin B1 in G2/M renal cancer cells with butyrolactone 1.
Int J Urol
2003
10:323-31
PubMed ID: 12757604
DOI: 10.1046/j.1442-2042.2003.00626.x
|
|
2561
Kasuya Y, Hosaka Y, Matsushima H, Goto T, Kitamura T
Differences in cell kinetic changes among renal cancer cell lines treated with interferon-alpha.
Int J Urol
2001
8:449-54
PubMed ID: 11555012
DOI: 10.1046/j.1442-2042.2001.00346.x
|
Back
Top
CELL BANK Website